Table 1 Lipid profile and atherogenic indexes in HS patients and controls
Parameter | HS patients (n = 78) | Controls (n = 62) | P |
|---|---|---|---|
Total cholesterol, mg/dL | 186.4 ± 33.6 | 202.7 ± 44.7 | 0.015 |
LDL-C, mg/dL | 116.6 ± 32.4 | 122.4 ± 29.2 | 0.28 |
HDL-C, mg/dL | 46.0 (41.0–56.3) | 52.5 (46.8–69.5) | 0.001 |
TG, mg/dL | 87.5 (68.8–117.3) | 74.0 (57.8–121.5) | 0.23 |
Non-HDL cholesterol, mg/dL | 138.5 (115.0–155.3) | 136.5 (118.3–160.3) | 0.45 |
ApoA1, mg/dL | 146.0 (127.0–167.0) | 151.0 (134.0–173.0) | 0.12 |
ApoB, mg/dL | 98.0 (79.5–112.3) | 90.0 (77.8–104.3) | 0.28 |
Lpa, mg/dL | 15.0 (7.6–27.5) | 15.5 (6.0–36.0) | 0.83 |
Total cholesterol / HDL-C | 4.09 (3.09–4.76) | 3.51 (2.83–4.40) | 0.06 |
LDL-C / HDL-C | 2.49 (1.85–3.12) | 2.19 (1.69–3.02) | 0.09 |
Non-HDL-C / HDL-C | 3.09 (2.09–3.76) | 2.51 (1.83–3.40) | 0.06 |
LDL-C / ApoB | 1.22 (1.09–1.29) | 1.35 (12.5–1.45) | < 0.0001 |
ApoB / ApoA1 | 0.65 (0.51–0.82) | 0.60 (0.47–0.70) | 0.09 |
AIP | −0.07 (− 0.24–0.05) | −0.23 (− 0.41–0.02) | 0.016 |